1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Moderate to Severe Primary Sjögren's Syndromedry eye syndrome, eye disorder, lacrimal apparatus disorderNot yet recruitingPhase 22026-10-01NCT07852234